Human platelet 5HT receptors: characterisation and functional association

Area of Science:

• Pharmacology
• Biochemistry
• Cell Biology

Background:

• Platelets play a crucial role in hemostasis and thrombosis.
• Serotonin (5-hydroxytryptamine or 5HT) is a key neurotransmitter and signaling molecule involved in various physiological processes, including platelet aggregation and uptake.
• Understanding the specific binding sites and mechanisms of 5HT interaction with platelets is essential for developing targeted therapies.

Purpose of the Study:

• To characterize the specific binding of [3H]5HT to human platelets.
• To identify and differentiate the kinetic parameters and characteristics of 5HT binding sites on platelets.
• To investigate the pharmacological profile of these binding sites using various drugs.

Main Methods:

• Incubation of normal human blood platelets with tritiated 5-hydroxytryptamine ([3H]5HT) at 2°C.
• Displacement assays using unlabeled 5HT to determine specific receptor binding.
• Kinetic analysis to establish binding parameters (KD and capacity) for different sites.
• Evaluation of drug inhibition and antagonism on [3H]5HT binding.

Main Results:

• A two-site model for platelet 5HT receptors was demonstrated: Site A (high affinity, KD 0.5-1 nM) and Site B (lower affinity, KD 15-36 nM).
• Non-specific [3H]5HT binding was resolved into passive and active saturable components.
• Tricyclic antidepressants and flupenthixol isomers showed differential inhibition, with affinities correlating to 5HT uptake.
• 5HT antagonists like methysergide, pizotifen, and mianserin competitively inhibited high-affinity binding.

Conclusions:

• Specific binding of [3H]5HT to intact human platelets was confirmed.
• The high-affinity site (Site A) is implicated in 5HT-induced platelet aggregation.
• The lower-affinity site (Site B) is associated with the active uptake of 5HT.
• Pharmacological profiles of the binding sites align with their proposed functional roles in platelet physiology.